Categories AlphaGraphs, Earnings, Health Care
DGX Infographic: Highlights of Quest Diagnostics’ Q4 2022 earnings
Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in adjusted profit and revenues.
On an adjusted basis, the healthcare company reported a net income of $1.98 per share for the December quarter, which is down 41% from the year-ago period. Unadjusted profit fell sharply to $101 million or $0.87 per share.
The bottom line was negatively impacted by a 15% decrease in revenues to $2.33 billion. The management expects full-year 2023 earnings to be between $7.61 per share and $8.21 per share.
“Quest had another strong year in 2022, with base business revenues growing more than 6% in the fourth quarter, and 5% for the full year. COVID-19 testing revenues declined as expected but still exceeded $1.4 billion in 2022,” said Quest’s CEO Jim Davis.
Most Popular
Broadcom (AVGO) reports higher Q3 revenue and profit; results beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenues and adjusted earnings for the third quarter of 2024 amid continued strong demand. The Q3 numbers also topped expectations. Earnings, excluding
Key takeaways from Hewlett Packard’s (HPE) Q3 2024 earnings report
Hewlett Packard Enterprise (NYSE: HPE) has delivered stronger-than-expected third-quarter results amid significant conversion in AI system revenues. The prospects for the company's AI server and edge computing businesses look promising
Hormel Foods (HRL): Factors that put a damper on the food company’s Q3 performance
Shares of Hormel Foods Corporation (NYSE: HRL) were up over 2% on Thursday. The stock is recovering from a fall it took a day ago after the company delivered mixed